KAKosh AgarwalMDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Special considerations before / during / after DAA therapy | Kosh Agarwal, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017HBV cure: what is coming in 5 – 10 years? | Patrick Kennedy, MDView Video
JRJürgen RockstrohMDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017EASL highlights 2017 | Jürgen Rockstroh, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Management of end-stage liver disease in HIV patients | Ana Morbey, MDView Video
VSVincent SorianoMD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017News on hepatitis delta and HIV infections | Vincent Soriano, MD, PhDView Video
KSKenneth ShermanMD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Hepatitis E in HIV | Kenneth Sherman, MD, PhDView Video
RSeCRui Sarmento e CastroMD, PhD, MPHVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Management of HCV in intravenous drug users: special considerations | Rui Sarmento e Castro, MD, PhDView Video
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017NASH and NAFLD in HIV: same or different? - Mariana Machado, MDView Slideset
JRJürgen RockstrohMDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017What challenges remain in viral hepatitis- Jürgen Rockstroh, MDView Slideset
NCNikoloz ChkhartishviliMD, MS, PhDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017HCV elimination program in Georgia: Successes and challenges- Nikoloz Chkhartishvili, MD, MS, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Regression of liver fibrosis in patients with chronic hepatitis C treated with direct acting anti-viral (DAA) therapy in the country of Georgia- E. DolmazashviliView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Treatment of cirrhotic HCV/HIV co-infected patients with DAAs- R. Sarmento e CastroView Slideset
